Market capitalization | $21.60b |
Enterprise Value | $24.79b |
PER (TTM) P/E ratio | 57.39 |
EV/FCF (TTM) EV/FCF | 40.45 |
EV/Sales (TTM) EV/Sales | 4.56 |
P/S ratio (TTM) P/S ratio | 3.97 |
P/B ratio (TTM) P/B ratio | 3.43 |
Dividend yield | 0.93% |
Last dividend (FY24) | $2.03 |
As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.
9 Analysts have issued a Steris forecast:
9 Analysts have issued a Steris forecast:
Mar '24 |
+/-
%
|
||
Net profit | -1.38 -1.38 |
101%
101%
|
|
Depreciation and amortization | 134 134 |
5%
5%
|
|
Share compensation | 8.95 8.95 |
2%
2%
|
|
Operating cash flow | 255 255 |
18%
18%
|
|
Investments | 92 92 |
28%
28%
|
|
Dividend paid | 51 51 |
10%
10%
|
|
Free cash flow | 163 163 |
13%
13%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.
Head office | Ireland |
CEO | Daniel Carestio |
Employees | 18,179 |
Founded | 2016 |
Website | www.steris.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.